❌

Normal view

Received — 24 September 2025 ⏭ Burning Rock Biotech Limited News Releases

Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

✇Burning Rock Biotech Limited News Releases
By: Burning Rock Biotech Limited News Releases
24 September 2025 at 14:43
TOKYO and GUANGZHOU, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd. (Riken Genesis) and Burning Rock Biotech Limited (NASDAQ: BNR, “Burning Rock”) today announced that the OncoGuide™ OncoScreen™ Plus CDx System based on OncoScreen™ Plus to be used as a companion diagnostic for
There are no more articles
❌